DPIIT recognised startup Government of India
Startup India
Likha Pharmaceuticals Private Limited
Likha Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.31 Cr
▲ 19% YoY
Net profit · FY 2025
₹3.57 Lakh
Net margin 2.7%
EBITDA · FY 2025
₹11.74 Lakh
EBITDA margin 8.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹19 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Likha Pharmaceuticals Private Limited
Data last updated:
Likha Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2020PTC141981. Its GSTIN is 29AAECL4474G1Z9 (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nazre Shruthi Sundar Rao and Nazre Sundarrao Naveen Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 004 E J Sriranga Apartment 1st Main Balaji Layout Uttrahalli Bangalore, Karnataka, India – 560061.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹3.57 Lakh (net margin 2.7%) and EBITDA of ₹11.74 Lakh (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
As per MCA filings, the company has open charges of ₹19 Lakh on record.
Likha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0065129).
Company details
CIN U51909KA2020PTC141981
Registration Number 141981
Incorporation Date 08 December 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0065129
Recognitions & Rankings of Likha Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0065129
Contact details
Likha Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 004 E J Sriranga Apartment 1st Main Balaji Layout Uttrahalli Bangalore, Karnataka, India – 560061
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Likha Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Likha Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Likha Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Likha Pharmaceuticals Private Limited, buy the company report.
Financials of Likha Pharmaceuticals Private Limited
FY 2025 filings availableLikha Pharmaceuticals Private Limited reported revenue of ₹1.31 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹1.31 Cr ▲ 19%
Net profit · FY 2025
₹3.57 Lakh margin 2.7%
EBITDA · FY 2025
₹11.74 Lakh margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 19% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Likha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Likha Pharmaceuticals Private Limited
Likha Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nazre Shruthi Sundar Rao | Director | 08 Dec 2020 | 5 Years 10 Months | Current |
| Nazre Sundarrao Naveen Kumar | Director | 08 Dec 2020 | 5 Years 10 Months | Current |
Auditor
Likha Pharmaceuticals Private Limited is audited by A D Y & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A D Y & CO | FY 2021 | 025370N |
Shareholding
The shareholding of Likha Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Likha Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹19 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2021 | 100479489 | Canara Bank | ₹19 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Likha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Likha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Likha Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 28, 2024.
Active EPFO establishments
1
GST
Likha Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECL4474G1Z9 | Karnataka | Active | 15 Jan 2021 |
To see the full GST registrations and return filing status of Likha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Likha Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Nazre Shruthi Sundar Rao was appointed as Director on 08 Dec 2020.
AGM
Likha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Likha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Canara Bank amounted to Rs. 19.00 Lakh with Charge ID 100479489 was registered on 24 Aug 2021.
Appointed
Nazre Shruthi Sundar Rao was appointed as Director.
Appointed
Nazre Sundarrao Naveen Kumar was appointed as Director.
Incorporation
08 Dec 2020
Likha Pharmaceuticals Private Limited was registered on 08 Dec 2020 with Roc Bangalore & aged 5 years 10 months as per MCA records.
Frequently asked questions
Likha Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 December 2020 (6+ years old) and is registered under CIN U51909KA2020PTC141981.
Likha Pharmaceuticals has 2 current directors:
- Nazre Shruthi Sundar Rao - Director
- Nazre Sundarrao Naveen Kumar - Director
The latest financial statements of Likha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Likha Pharmaceuticals is 29AAECL4474G1Z9, registered in Karnataka.
The CIN (Corporate Identification Number) of Likha Pharmaceuticals is U51909KA2020PTC141981. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Likha Pharmaceuticals was incorporated on 08 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Nazre Shruthi Sundar Rao was appointed as Director on 08 Dec 2020. Nazre Sundarrao Naveen Kumar was appointed as Director on 08 Dec 2020.
Yes, Likha Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Likha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0065129).
The registered office of Likha Pharmaceuticals is at Flat No. 004 E J Sriranga Apartment 1st Main Balaji Layout Uttrahalli Bangalore, Karnataka, India – 560061.